Title,Authors,Platform,Cited_url,Cited_count,Year
Multiplex genome engineering using CRISPR/Cas systems,"L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, ...","Science 339 (6121), 819-823",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4611939203796302875,9303,2013
 genome editing using ,"FA Ran, L Cong, WX Yan, DA Scott, JS Gootenberg, AJ Kriz, B Zetsche, ...","Nature 520 (7546), 186",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10611619311386384827,1409,2015
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription,"F Zhang, L Cong, S Lodato, S Kosuri, GM Church, P Arlotta","Nature biotechnology 29 (2), 149-153","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15535450720308121498,7272868990588381063",879,2011
Optical control of mammalian endogenous transcription and epigenetic states,"S Konermann, MD Brigham, AE Trevino, PD Hsu, M Heidenreich, L Cong, ...","Nature 500 (7463), 472",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13599154321815964313,701,2013
A transcription activator-like effector toolbox for genome engineering,"NE Sanjana, L Cong, Y Zhou, MM Cunniff, G Feng, F Zhang","Nature protocols 7 (1), 171-192","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8782252682237121692,14839536790952946929",677,2012
In vivo gene editing in dystrophic mouse muscle and muscle stem cells,"M Tabebordbar, K Zhu, JKW Cheng, WL Chew, JJ Widrick, WX Yan, ...","Science 351 (6271), 407-411",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12732832814789909523,669,2016
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens,"W Li, H Xu, T Xiao, L Cong, MI Love, F Zhang, RA Irizarry, JS Liu, ...","Genome biology 15 (12), 554",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12847871731360987219,369,2014
Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains,"L Cong, R Zhou, Y Kuo, M Cunniff, F Zhang","Nature communications 3, 968",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13761761066570019765,343,2012
Sequence determinants of improved CRISPR sgRNA design,"H Xu, T Xiao, CH Chen, W Li, CA Meyer, Q Wu, D Wu, L Cong, F Zhang, ...","Genome research 25 (8), 1147-1157",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8051706563218438872,256,2015
Genome-scale promoter engineering by coselection MAGE,"HH Wang, H Kim, L Cong, J Jeong, D Bang, GM Church","Nature methods 9 (6), 591","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13721041422106038443,7977232138071207161",227,2012
Crystal structure of Staphylococcus aureus Cas9,"H Nishimasu, L Cong, WX Yan, FA Ran, B Zetsche, Y Li, A Kurabayashi, ...","Cell 162 (5), 1113-1126",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2520166644558731651,215,2015
"Crispr-cas component systems, methods and compositions for sequence manipulation","F Zhang, DO BIKARD, L Cong, DBT COX, P Hsu, W Jiang, LIN Shauiliang, ...",,,184,2014
"Crispr-cas component systems, methods and compositions for sequence manipulation","F Zhang, DO BIKARD, L Cong, DBT COX, P Hsu, W Jiang, LIN Shauiliang, ...",,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17882478905411891978,1499117341110768475,2444835469926108776",184,2014
"Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains","F Zhang, L Cong, RJ Platt, RAN Fei, NE Sanjana",,,183,2016
"Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains","F Zhang, L Cong, RJ Platt, RAN Fei, NE Sanjana",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4827003044703088207,183,2016
"Engineering of systems, methods and optimized guide compositions for sequence manipulation","F Zhang, L Cong, P Hsu, RAN Fei",,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10075300634614963106,15969772393443040108",165,2014
"CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes","L Cong, F Zhang","US Patent 8,932,814",,157,2015
"CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes","L Cong, F Zhang","US Patent 8,932,814","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9608627648959990737,2758397692350672921",157,2015
"Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains","F Zhang, L Cong, RJ Platt, NE Sanjana","US Patent 8,999,641",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3495400369099660543,156,2015
"CRISPR-Cas component systems, methods and compositions for sequence manipulation","L Cong, F Zhang","US Patent 8,871,445",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5982492576623496613,142,2014
A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells,"M Singer, C Wang, L Cong, ND Marjanovic, MS Kowalczyk, H Zhang, ...","Cell 166 (6), 1500-1511. e9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18072213978298809186,141,2016
Genome engineering using CRISPR-Cas9 system,"L Cong, F Zhang","Chromosomal Mutagenesis, 197-217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6360950291084235892,137,2015
"Engineering of systems, methods and optimized guide compositions for sequence manipulation","F Zhang, L Cong, P Hsu, RAN Fei","US Patent App. 14/104,990",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6144007950681476845,97,2014
"Crispr-cas component systems, methods and compositions for sequence manipulation","F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ...","US Patent App. 14/105,035",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10367501525750474314,92,2014
"CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes","F Zhang, L Cong, RAN Fei","US Patent App. 14/105,031",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11212189856068218758,83,2014
"Delivery and use of the crispr-cas systems, vectors and compositions for hepatic targeting and therapy","F Zhang, L Cong, RAN Fei",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3373922242443600004,70,2014
Recombinant virus and preparations thereof,"F Zhang, MD Brigham, L Cong, S Konermann","US Patent App. 14/213,991","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3522799083293088206,8522330004682125136",69,2014
Global microRNA depletion suppresses tumor angiogenesis,"S Chen, Y Xue, X Wu, C Le, A Bhutkar, EL Bell, F Zhang, R Langer, ...","Genes & development 28 (10), 1054-1067",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7039438399917276508,61,2014
Normal patterns of angiogenesis and extracellular matrix deposition in chick chorioallantoic membranes are disrupted by mainstream and sidestream cigarette smoke,"G Melkonian, C Le, W Zheng, P Talbot, M Martins-Green","Toxicology and applied pharmacology 163 (1), 26-37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11850746558175164004,61,2000
"Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains","F Zhang, L Cong, RJ Platt, NE Sanjana, RAN Fei","US Patent App. 14/738,398",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14551163719189121940,56,2015
Inducible dna binding proteins and genome perturbation tools and applications thereof,"F Zhang, M Brigham, L Cong, S Konermann, NE SANJAN",,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5415268952958561260,14794882587674257991",50,2014
RBPJ controls development of pathogenic Th17 cells by regulating IL-23 receptor expression,"GM zu Horste, C Wu, C Wang, L Cong, M Pawlak, Y Lee, W Elyaman, ...","Cell reports 16 (2), 392-404",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12490176263284772925,46,2016
"Engineering of systems, methods and optimized guide compositions for sequence manipulation","F Zhang, L Cong","US Patent App. 14/703,511",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6459165866010219382,46,2015
Transcription activator-like effectors,"F Zhang, L Cong, S Kosuri, GM Church","US Patent 9,499,592",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11216305158314398566,43,2016
"Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components","F Zhang, RAN Fei, M Heidenreich, L SWIECH",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1566361530468349885,35,2014
Efficient generation of transcriptomic profiles by random composite measurements,"B Cleary, L Cong, A Cheung, ES Lander, A Regev","Cell 171 (6), 1424-1436. e18",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7814631424821635365,30,2017
"Engineering of systems, methods and optimized guide compositions for sequence manipulation","F Zhang, L Cong, P Hsu, RAN Fei","US Patent App. 15/230,025",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12521460329818057853,27,2016
"CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes","F Zhang, L Cong, RAN Fei","US Patent App. 15/229,702",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7483030808355374967,26,2017
Nucleotide-specific recognition sequences for designer TAL effectors,"F Zhang, L Cong","US Patent 8,450,107",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18158542667168919966,24,2013
Nucleotide-specific recognition sequences for designer TAL effectors,"F Zhang, L Cong","US Patent 8,614,092",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4387029719772404679,22,2013
Nucleotide-specific recognition sequences for designer TAL effectors,"F Zhang, L Cong","US Patent 8,481,309","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9556084908076959003,14011175868300184982",22,2013
Nucleotide-specific recognition sequences for designer TAL effectors,"F Zhang, L Cong","US Patent 8,507,272",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1491884314561584098,21,2013
Nucleotide-Specific Recognition Sequences For Designer TAL Effectors,"F Zhang, L Cong","US Patent App. 13/732,287",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11004117982765664384,16,2013
Composite measurements and molecular compressed sensing for highly efficient transcriptomics. bioRxiv,"B Cleary, L Cong, E Lander, A Regev",Posted January,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16775547856355854025,510200330609279234",10,2017
Compositions and methods of treating head and neck cancer,"L Cong, AM Egloff, LA Garraway, JR Grandis, ES Lander, N Stransky, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7950818724745548238,7,2013
Nucleotide-specific recognition sequences for designer tal effectors,"F Zhang, L Cong, S Locascio","US Patent App. 14/292,278",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13118788475107414273,3,2014
Longitudinal single cell profiling of regulatory T cells identifies IL-33 as a driver of tumor immunosuppression,"A Li, RH Herbst, D Canner, JM Schenkel, OC Smith, JY Kim, M Hillman, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7424622100500543816,1,2019
"Crispr-cas component systems, methods and compositions for sequence manipulation","F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ...","US Patent App. 15/230,161",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4864196011847146649,1,2018
CRISPR: Groundbreaking technology for RNA-guided genome engineering,L Cong,"Analytical biochemistry 532, 87-89",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9687029319562338249,1,2017
"Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing","L Cong, DBT Cox, M Heidenreich, RJ Platt, L Swiech, F Zhang","US Patent App. 15/179,799",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11483146678746944294,1,2016
In Vivo Genome Engineering With AAV Vector Carrying CRISPR-Cas9 System,"L Cong, WX Yan, F Ran, B Zetsche, F Zhang","MOLECULAR THERAPY 22, S214-S214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9072355934067272400,1,2014
IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development,"A Li, RH Herbst, D Canner, JM Schenkel, OC Smith, JY Kim, M Hillman, ...","Cell Reports 29 (10), 2998-3008. e8",,0,2019
Inducible dna binding proteins and genome perturbation tools and applications thereof,"F Zhang, M Brigham, L Cong, S Konermann, N Sanjana","US Patent App. 16/297,560",,0,2019
CRISPR/Cas9 Gene Targeting,L Cong,"Stem Cells and Development 28 (11), 709-709",,0,2019
Take Risks and Constantly Challenge the Status Quo.,L Cong,"Stem cells and development 28 (11), 709",,0,2019
Compositions and methods for evaluating and modulating immune responses by detecting and targeting pou2af1,"A Regev, AC Anderson, L Cong, VK Kuchroo, M Singer, C Wang","US Patent App. 15/966,244",,0,2019
Compositions and methods for evaluating and modulating immune responses by detecting and targeting gata3,"A Regev, AC Anderson, L Cong, VK Kuchroo, M Singer, C Wang","US Patent App. 15/966,290",,0,2019
Compositions and methods for evaluating and modulating immune responses by use of immune cell gene signatures,"A Regev, AC Anderson, L Cong, VK Kuchroo, M Singer, C Wang","US Patent App. 15/966,324",,0,2019
Combined Computational–Experimental Approach to Explore the Molecular Mechanism of SaCas9 with a Broadened DNA Targeting Range,"B Luan, G Xu, M Feng, L Cong, R Zhou","Journal of the American Chemical Society 141 (16), 6545-6552",,0,2019
"Crispr-cas component systems, methods and compositions for sequence manipulation","F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ...","US Patent App. 15/967,510",,0,2019
"Crispr-cas component systems, methods and compositions for sequence manipulation","F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ...","US Patent App. 15/967,495",,0,2019
Nucleotide-specific recognition sequences for designer tal effectors,"F Zhang, L Cong","US Patent App. 16/012,609",,0,2019
"CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes","F Zhang, L Cong, RAN Fei","US Patent App. 15/967,464",,0,2018
Systems and methods for determining relative abundances of biomolecules,"A Regev, ES Lander, B Cleary, L Cong","US Patent App. 15/771,981",,0,2018
Molecular profiling of regulatory T cells in a genetic mouse model of lung adenocarcinoma.,"A Li, A Bhutkar, DA Canner, R Herbst, OC Smith, JY Kim, L Cong, ...","CANCER RESEARCH 78 (10), 76-76",,0,2018
Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction,"A Regev, B Adamson, B Cleary, L Cong, A Dixit, J Gaublomme, ...",,,0,2017
Transcription Activator-Like Effectors,"F Zhang, L Cong, S Kosuri, GM Church","US Patent App. 15/334,341",,0,2017
Abstract A10: A distinct gene module for T cell dysfunction uncoupled from T cell activation and controlled by metallothioneins,"M Singer, C Wang, L Cong, ND Marjanovic, MS Kowalczyk, H Zhang, ...","Cancer Immunology Research 5 (3 Supplement), A10-A10",,0,2017
"Ingeniería de sistemas, métodos y composiciones de guía optimizadas para manipulación de secuencias","F Zhang, L Cong, P Hsu, RAN Fei",,,0,2017
"Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation","F Zhang, YAN Winston, O Nureki, K Zheng, L Cong, H Nishimasu, ...",,,0,2016
Transcription activator-like effectors,"F Zhang, L Cong, S Kosuri, GM Church","President and Fellows of Harvard College, Cambridge, MA (United States)",,0,2016
Abstract B085: Combining transcriptomic profiling and genome engineering to dissect regulation of tumor immunology,"L Cong, M Singer, C Wang, J Kwon, A Anderson, O Rozenblatt-Rosen, ...","Cancer Immunology Research 4 (11 Supplement), B085-B085",,0,2016
uthor Man,"M Singer, C Wang, L Cong, ND Marjanovic, MS Kowalczyk, H Zhang, ...","Cell 166, 1500-1511",,0,2016
"Modification by genetic technology and optimization of systems, methods and compositions for the manipulation of sequences with functional domains","F Zhang, L Cong, RJ PLATT, RAN Fei, NE SANJANA",,,0,2016
"Systems engineering, methods and guide compositions optimized for sequence manipulation","F Zhang, L Cong, P Hsu, RAN Fei",,,0,2015
CRISPR/Cas9 介导的绵羊胎儿成纤维细胞肌肉生长抑制素基因敲除研究,李聪， 曹文广,"中国畜牧兽医 42 (11), 2813-2821",,0,2015
Recombinant virus and preparations thereof,"F Zhang, MD Brigham, L Cong, S KONERMANN",,,0,2014
"Fabrication et optimisation de systèmes, de procédés et de compositions pour la manipulation de séquence avec des domaines fonctionnels","F Zhang, L Cong, RJ PLATT, RAN Fei, NE SANJANA",,,0,2014
Genome Engineering Technology and Its Application in Mammalian Cells,L Cong,Harvard University,,0,2014
Nucleotide-specific recognition sequences for designer tal effectors,"L Cong, S LOCASCIO, F Zhang",,,0,2013
Analysis of Neuronal Circuits with Optogenetics,"F Zhang, L Cong, GD Stuber, A Adamantidis, K Deisseroth","Controlled Genetic Manipulations, 207-223",,0,2012
Cigarette smoke alters angiogenesis through an effect on the extracellular matrix (ECM).,"G Melkonian, C Le, M Martins-Green, P Talbot","MOLECULAR BIOLOGY OF THE CELL 9, 171A-171A",,0,1998
